Twelve months after bivalent vaccination, anti-S1 antibodies were with a median (IQR) index of 697 (206–950) as compared to 87 (34–450), significantly higher in individuals with breakthrough infections as compared to individuals without breakthrough infections during follow-up (p < 0.001; Figure 4A). The gene discussed is PSMD1; the disease is infection.